https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.htmlOne place for news and notices from 2 countries/regions: Taiwan, 71 items from 4 sources; Japan, 33 items from 1 source.One edition every 180 minutes: every item from every source received in the period, with the original link.en https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2346441https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2346441Sat, 29 Aug 2026 01:00:00 +0900Taiwan臺灣證券交易所台端興業 announced that investment balances in four funds and redemption proceeds remain outstanding. Their fair value was assessed at 0, signaling significant financial risk and an impact on shareholders’ equity. https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2346440https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2346440Sat, 29 Aug 2026 01:00:00 +0900Taiwan臺灣證券交易所PharmaEssentia’s new drug BESREMi has received U.S. FDA approval to treat adults with essential thrombocythemia. The expanded indication is expected to help develop the U.S. market, and the company has launched related sales and marketing plans. https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2346430https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2346430Fri, 28 Aug 2026 01:00:00 +0900Taiwan臺灣證券交易所A subsidiary of Zhen Ding-KY acquired equipment in Thailand for about 1.078 billion New Taiwan dollars for business operations. The price was determined through competitive bidding and negotiations based on market rates. https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2350652https://ainews.idaeo.ai/180m/20260830-15/index-en-p2.html#n2350652Mon, 01 Jun 2026 01:00:00 +0900Taiwan臺灣證券交易所鼎炫投控 reported its financial results for the second quarter of 2026, with earnings per share of 3.91 yuan and steady revenue and profit.